4-Methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells
Authors:
- 23 October 2012
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 29 (1) , 335-342
Abstract
Hyaluronan (HA), a major component of the extracellular matrix (ECM), is synthesized by HA synthase (HAS) 1, HAS2 and HAS3 and is intricately involved in cell growth and metastasis. The HA synthesis inhibitor 4-methylumbelliferone (4-MU) has been reported to exhibit anticancer properties in various types of malignant tumors. However, the underlying mechanisms at the molecular and cellular levels remain unclear. In this study, to establish an animal model for studying the function of HA in human breast cancer, we investigated the antitumor effects of 4-MU using canine mammary tumor (CF33) cells. First, we investigated the effects of 4-MU on HA production in CF33 cells. Quantitative analysis of HA in culture media showed that 4-MU inhibited HA synthesis, accompanied by downregulation of HAS2 mRNA levels, in a dose-dependent manner at 24-72 h. Additionally, we observed a 4-MU-mediated decrease in the extent of the cell-associated HA matrix. We examined the effect of 4-MU on cell growth and apoptosis in CF33 cells. 4-MU markedly inhibited cell proliferation and induced apoptosis in CF33 cells. In particular, our experiments showed that the mechanism of 4-MU-induced apoptosis in CF33 cells involved increased levels of expression of pro-apoptotic BAX mRNA and protein molecules. These data suggest that 4-MU may be a candidate therapeutic agent for the treatment of canine mammary tumors. Furthermore, this study provides the first indication that the canine mammary tumor may be a suitable model for comparative study of the function of HA in human breast cancer.Keywords
This publication has 40 references indexed in Scilit:
- Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal CellsCancer Research, 2012
- Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivoBritish Journal of Cancer, 2011
- Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-κB (NF-κB) PathwayJournal of Biological Chemistry, 2010
- Antitumor Activity of Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone in Prostate Cancer CellsCancer Research, 2010
- 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3Experimental Cell Research, 2009
- Comparative expression pathway analysis of human and canine mammary tumorsBMC Genomics, 2009
- In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the LiverThe American Journal of Pathology, 2007
- Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cellsInternational Journal of Cancer, 2007
- A hyaluronan synthase suppressor, 4‐methylumbelliferone, inhibits liver metastasis of melanoma cellsFEBS Letters, 2005
- Mammalian Hyaluronan SynthasesIUBMB Life, 2002